Regulation of hepatic ApoC3 expression by PGC-1β mediates hypolipidemic effect of nicotinic acid

Cell Metabolism

Volumn 12, Issue 4, 2010, Pages 411-419

  Hernandez, Carlos ^a,b   Molusky, Matthew ^a,b   Li, Yaqiang ^a,b   Li, Siming ^a,b   Lin, Jiandie D ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; ESTROGEN RELATED RECEPTOR ALPHA; FATTY ACID; NICOTINIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR COACTIVATOR 1 BETA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; GENE CLUSTER; GENE EXPRESSION; HYPERTRIGLYCERIDEMIA; HYPOLIPEMIA; LIPID DEGRADATION; LIVER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; APOLIPOPROTEIN C-III; GENE EXPRESSION REGULATION; HYPOLIPIDEMIC AGENTS; LIPID METABOLISM; LIVER; MICE; MICE, KNOCKOUT; NIACIN; TRANS-ACTIVATORS; TRIGLYCERIDES;

MUS;

EID: 77957674906     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2010.09.001     Document Type: Article

References (49)

1. J. Altomonte, L. Cong, S. Harbaran, A. Richter, J. Xu, M. Meseck, and H.H. Dong Foxo1 mediates insulin action on apoC-III and triglyceride metabolism J. Clin. Invest. 114 2004 1493 1503
2. Z. Benyo, A. Gille, J. Kero, M. Csiky, M.C. Suchankova, R.M. Nusing, A. Moers, K. Pfeffer, and S. Offermanns GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing J. Clin. Invest. 115 2005 3634 3640
3. J.G. Bisaha, T.C. Simon, J.I. Gordon, and J.L. Breslow Characterization of an enhancer element in the human apolipoprotein C-III gene that regulates human apolipoprotein A-I gene expression in the intestinal epithelium J. Biol. Chem. 270 1995 19979 19988
4. J.L. Breslow Genetics of lipoprotein abnormalities associated with coronary artery disease susceptibility Annu. Rev. Genet. 34 2000 233 254
5. J.D. Brunzell Clinical practice. Hypertriglyceridemia N. Engl. J. Med. 357 2007 1009 1017
6. J.C. Carrier, G. Deblois, C. Champigny, E. Levy, and V. Giguere Estrogen-related receptor alpha (ERRalpha) is a transcriptional regulator of apolipoprotein A-IV and controls lipid handling in the intestine J. Biol. Chem. 279 2004 52052 52058
7. Y. Cohen, I. Raz, G. Merin, and B. Mozes Comparison of factors associated with 30-day mortality after coronary artery bypass grafting in patients with versus without diabetes mellitus. Israeli Coronary Artery Bypass (ISCAB) Study Consortium Am. J. Cardiol. 81 1998 7 11
8. B.N. Finck, and D.P. Kelly PGC-1 coactivators: inducible regulators of energy metabolism in health and disease J. Clin. Invest. 116 2006 615 622
9. A. Gille, E.T. Bodor, K. Ahmed, and S. Offermanns Nicotinic acid: pharmacological effects and mechanisms of action Annu. Rev. Pharmacol. Toxicol. 48 2008 79 106
10. I.J. Goldberg Clinical review 124: Diabetic dyslipidemia: causes and consequences J. Clin. Endocrinol. Metab. 86 2001 965 971
11. C. Handschin The biology of PGC-1alpha and its therapeutic potential Trends Pharmacol. Sci. 30 2009 322 329
12. M. Hernandez, S.D. Wright, and T.Q. Cai Critical role of cholesterol ester transfer protein in nicotinic acid-mediated HDL elevation in mice Biochem. Biophys. Res. Commun. 355 2007 1075 1080
13. J.M. Huss, R.P. Kopp, and D.P. Kelly Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha J. Biol. Chem. 277 2002 40265 40274
14. Y. Ito, N. Azrolan, A. O'Connell, A. Walsh, and J.L. Breslow Hypertriglyceridemia as a result of human apo CIII gene expression in transgenic mice Science 249 1990 790 793
15. Y. Kamei, H. Ohizumi, Y. Fujitani, T. Nemoto, T. Tanaka, N. Takahashi, T. Kawada, M. Miyoshi, O. Ezaki, and A. Kakizuka PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity Proc. Natl. Acad. Sci. USA 100 2003 12378 12383
16. F. Karpe, and K.N. Frayn The nicotinic acid receptor - a new mechanism for an old drug Lancet 363 2004 1892 1894
17. S. Kathiresan, O. Melander, C. Guiducci, A. Surti, N.P. Burtt, M.J. Rieder, G.M. Cooper, C. Roos, B.F. Voight, and A.S. Havulinna Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans Nat. Genet. 40 2008 189 197
18. C.Q. Lai, L.D. Parnell, and J.M. Ordovas The APOA1/C3/A4/A5 gene cluster, lipid metabolism and cardiovascular disease risk Curr. Opin. Lipidol. 16 2005 153 166
19. P. Lefebvre, G. Chinetti, J.C. Fruchart, and B. Staels Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis J. Clin. Invest. 116 2006 571 580
20. S. Li, C. Liu, N. Li, T. Hao, T. Han, D.E. Hill, M. Vidal, and J.D. Lin Genome-wide coactivation analysis of PGC-1alpha identifies BAF60a as a regulator of hepatic lipid metabolism Cell Metab. 8 2008 105 117
21. J. Lin, P. Puigserver, J. Donovan, P. Tarr, and B.M. Spiegelman Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta), a novel PGC-1-related transcription coactivator associated with host cell factor J. Biol. Chem. 277 2002 1645 1648
22. J. Lin, P.T. Tarr, R. Yang, J. Rhee, P. Puigserver, C.B. Newgard, and B.M. Spiegelman PGC-1beta in the regulation of hepatic glucose and energy metabolism J. Biol. Chem. 278 2003 30843 30848
23. J. Lin, P.H. Wu, P.T. Tarr, K.S. Lindenberg, J. St-Pierre, C.Y. Zhang, V.K. Mootha, S. Jager, C.R. Vianna, and R.M. Reznick Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice Cell 119 2004 121 135
24. J. Lin, C. Handschin, and B.M. Spiegelman Metabolic control through the PGC-1 family of transcription coactivators Cell Metab. 1 2005 361 370
25. J. Lin, R. Yang, P.T. Tarr, P.H. Wu, C. Handschin, S. Li, W. Yang, L. Pei, M. Uldry, and P. Tontonoz Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP Cell 120 2005 261 273
26. C. Liu, S. Li, T. Liu, J. Borjigin, and J.D. Lin Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism Nature 447 2007 477 481
27. N. Maeda, H. Li, D. Lee, P. Oliver, S.H. Quarfordt, and J. Osada Targeted disruption of the apolipoprotein C-III gene in mice results in hypotriglyceridemia and protection from postprandial hypertriglyceridemia J. Biol. Chem. 269 1994 23610 23616
28. M. Merkel, B. Loeffler, M. Kluger, N. Fabig, G. Geppert, L.A. Pennacchio, A. Laatsch, and J. Heeren Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase J. Biol. Chem. 280 2005 21553 21560
29. T. Mishiro, K. Ishihara, S. Hino, S. Tsutsumi, H. Aburatani, K. Shirahige, Y. Kinoshita, and M. Nakao Architectural roles of multiple chromatin insulators at the human apolipoprotein gene cluster EMBO J. 28 2009 1234 1245
30. Y. Nagai, S. Yonemitsu, D.M. Erion, T. Iwasaki, R. Stark, D. Weismann, J. Dong, D. Zhang, M.J. Jurczak, and M.G. Loffler The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance Cell Metab. 9 2009 252 264
31. L.A. Pennacchio, M. Olivier, J.A. Hubacek, J.C. Cohen, D.R. Cox, J.C. Fruchart, R.M. Krauss, and E.M. Rubin An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing Science 294 2001 169 173
32. P. Puigserver, G. Adelmant, Z. Wu, M. Fan, J. Xu, B. O'Malley, and B.M. Spiegelman Activation of PPARgamma coactivator-1 through transcription factor docking Science 286 1999 1368 1371
33. E. Raspe, H. Duez, P. Gervois, C. Fievet, J.C. Fruchart, S. Besnard, J. Mariani, A. Tedgui, and B. Staels Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha J. Biol. Chem. 276 2001 2865 2871
34. R. Saxena, B.F. Voight, V. Lyssenko, N.P. Burtt, P.I. de Bakker, H. Chen, J.J. Roix, S. Kathiresan, J.N. Hirschhorn, and M.J. Daly Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels Science 316 2007 1331 1336
35. S.N. Schreiber, D. Knutti, K. Brogli, T. Uhlmann, and A. Kralli The transcriptional coactivator PGC-1 regulates the expression and activity of the orphan nuclear receptor estrogen-related receptor alpha (ERRalpha) J. Biol. Chem. 278 2003 9013 9018
36. T. Soga, M. Kamohara, J. Takasaki, S. Matsumoto, T. Saito, T. Ohishi, H. Hiyama, A. Matsuo, H. Matsushime, and K. Furuichi Molecular identification of nicotinic acid receptor Biochem. Biophys. Res. Commun. 303 2003 364 369
37. S. Tunaru, J. Kero, A. Schaub, C. Wufka, A. Blaukat, K. Pfeffer, and S. Offermanns PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect Nat. Med. 9 2003 352 355
38. K.W. van Dijk, P.C. Rensen, P.J. Voshol, and L.M. Havekes The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr. Opin. Lipidol. 15 2004 239 246
39. N. Vu-Dac, P. Gervois, I.P. Torra, J.C. Fruchart, V. Kosykh, T. Kooistra, H.M. Princen, J. Dallongeville, and B. Staels Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids J. Clin. Invest. 102 1998 625 632
40. A.E. Wallberg, S. Yamamura, S. Malik, B.M. Spiegelman, and R.G. Roeder Coordination of p300-mediated chromatin remodeling and TRAP/mediator function through coactivator PGC-1alpha Mol. Cell 12 2003 1137 1149
41. C.S. Wang, W.J. McConathy, H.U. Kloer, and P. Alaupovic Modulation of lipoprotein lipase activity by apolipoproteins. Effect of apolipoprotein C-III J. Clin. Invest. 75 1985 384 390
42. W. Wang, A. Basinger, R.A. Neese, B. Shane, S.A. Myong, M. Christiansen, and M.K. Hellerstein Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production Am. J. Physiol. Endocrinol. Metab. 280 2001 E540 E547
43. C.J. Willer, S. Sanna, A.U. Jackson, A. Scuteri, L.L. Bonnycastle, R. Clarke, S.C. Heath, N.J. Timpson, S.S. Najjar, and H.M. Stringham Newly identified loci that influence lipid concentrations and risk of coronary artery disease Nat. Genet. 40 2008 161 169
44. A. Wise, S.M. Foord, N.J. Fraser, A.A. Barnes, N. Elshourbagy, M. Eilert, D.M. Ignar, P.R. Murdock, K. Steplewski, and A. Green Molecular identification of high and low affinity receptors for nicotinic acid J. Biol. Chem. 278 2003 9869 9874
45. C. Wolfrum, and M. Stoffel Coactivation of Foxa2 through Pgc-1beta promotes liver fatty acid oxidation and triglyceride/VLDL secretion Cell Metab. 3 2006 99 110
46. J. Wysocka, M.P. Myers, C.D. Laherty, R.N. Eisenman, and W. Herr Human Sin3 deacetylase and trithorax-related Set1/Ash2 histone H3-K4 methyltransferase are tethered together selectively by the cell-proliferation factor HCF-1 Genes Dev. 17 2003 896 911
47. J. Ye, J.Z. Li, Y. Liu, X. Li, T. Yang, X. Ma, Q. Li, Z. Yao, and P. Li Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B Cell Metab. 9 2009 177 190
48. J.C. Yoon, P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C.R. Kahn, and D.K. Granner Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1 Nature 413 2001 131 138 (Pubitemid 32867868)
49. V.I. Zannis, H.Y. Kan, A. Kritis, E.E. Zanni, and D. Kardassis Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo Curr. Opin. Lipidol. 12 2001 181 207